Order Article Reprints

Özkan B, Altuntaş E, Ünlü Ü, Doğan HH, Özsoy Y, Çakır Koç R. Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics. 2023; 15(8):2055. https://doi.org/10.3390/pharmaceutics15082055

Özkan, Burcu, Ebru Altuntaş, Ümmühan Ünlü, Hasan Hüseyin Doğan, Yıldız Özsoy, and Rabia Çakır Koç. 2023. "Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus" Pharmaceutics 15, no. 8: 2055. https://doi.org/10.3390/pharmaceutics15082055

Özkan, B., Altuntaş, E., Ünlü, Ü., Doğan, H. H., Özsoy, Y., & Çakır Koç, R. (2023). Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus. Pharmaceutics, 15(8), 2055. https://doi.org/10.3390/pharmaceutics15082055